Acute liver failure

Diseases of the Liver and Biliary System in Children: Third Edition

Volumn , Issue , 2009, Pages 169-188

  Whitington, Peter F ^a,b   Alonso, Estella M ^c   Squires, Robert H ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889859165     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300536.ch7     Document Type: Chapter

References (103)

1. Sanyal AJ, Stravitz RT. Acute liver failure. In: Zakim D, Boyer TD, eds. Hepatology, 4th ed. Philadelphia: Saunders, 2003: 445-96.
2. Whitington PF, Alonso EM. Fulminant hepatitis in children: evidence for an unidentified hepatitis virus. J Pediatr Gastroenterol Nutr 2001;33:529-36.
3. Williams R. Classification, etiology, and considerations of outcome in acute liver failure. Semin Liver Dis 1996;16:343-8.
4. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970;2:282-98.
5. Durand P, Debray D, Mandel R, et al. Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center. J Pediatr 2001;139:871-6.
6. Psacharopoulos HT, Mowat AP, Davies M, Portmann B, Silk DBA, Williams R. Fulminant hepatic failure in childhood: an analysis of 31 cases. Arch Dis Child 1980;55:252-8.
7. Saunders SJ, Hickman R, MacDonald R, Terblanche J. The treatment of acute liver failure. Prog Liver Dis 1972;3:333-44.
8. Lee WS, McKiernan P, Kelly DA. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United Kingdom. J Pediatr Gastroenterol Nutr 2005;40:575-81.
9. Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006;148:652-8.
10. Debray D, Cullufi P, Devictor D, Fabre M, Bernard O. Liver failure in children with hepatitis A. Hepatology 1997;26:1018-22.
11. Averhoff F, Shapiro CN, Bell BP, et al. Control of hepatitis A through routine vaccination of children. JAMA 2001;286: 2968-73.
12. Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986;6: 648-51.
13. Schiodt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999;5:29-34.
14. Teo EK, Ostapowicz G, Hussain M, Lee WM, Fontana RJ, Lok AS. Hepatitis B infection in patients with acute liver failure in the United States. Hepatology 2001;33:972-6.
15. Chang MH, Lee CY, Chen DS, Hsu HC, Lai MY. Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus. J Pediatr 1986;3:34-8.
16. Gimson AES, White YS, Eddleston WF, Williams R. Clinical and prognostic differences in fulminant hepatitis type A, B and nonA, non-B. Gut 1983;24:1194-8.
17. Kao J, Hsu H, Shau W, Chang M, Chen D. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr 2001;139:349-52.
18. Farci P, Alter HJ, Shimoda A, et al. Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med 1996;335:631-4.
19. Feranchak AP, Tyson RW, Narkewicz MR, Karrer FM, Sokol RJ. Fulminant Epstein-Barr viral hepatitis: orthotopic liver transplantation and review of the literature. Liver Transpl Surg 1998;4:469-76.
20. Dirix L, Polson RJ, Richardson A, Williams R. Primary sepsis presenting as fulminant hepatic failure. QJM 1989;271:1037-4.
21. Whitington PF, Soriano HE, Alonso EM. Fulminant hepatic failure in children. In: Suchy FJ, Sokol RJ, Balistreri WF, eds. Liver Disease in Children, 2nd ed. Philadelphia: Lippincott, Williams and Wilkins, 2001: 63-88.
22. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004;10:1018-23.
23. Arundel C, Lewis JH. Drug-induced liver disease in 2006. Curr Opin Gastroenterol 2007;23:244-54.
24. Mahadevan SBK, McKiernan PJ, Davies P, Kelly DA. Acetaminophen-induced hepatotoxicity in children. Arch Dis Child 2006;91:598-603.
25. Lee WM. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 2004;40:6-9.
26. Davern TJ 2nd, James LP, Hinson JA, et al. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology 2006;130:687-94.
27. Mutimer DJ, Ayres RC, Neuberger JM, et al. Serious acetaminophen poisoning and the results of liver transplantation. Gut 1994;35:809-14.
28. Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998;27:1050-5.
29. Reich DJ, Fiel I, Guarrera JV, et al. Liver transplantation for autoimmune hepatitis. Hepatology 2000;32(4 Pt 1):693-700.
30. Maggiore G, Porta G, Bernard O, et al. Autoimmune hepatitis with initial presentation as acute hepatic failure in young children. J Pediatr 1990;116:280-2.
31. Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-7.
32. Whitington PF. Metabolic liver disease in childhood. In: Kaplowitz N, ed. Liver and Biliary Diseases, 2nd ed. Baltimore: Williams and Wilkins, 1996: 511-34.
33. Thomson M, McKiernan P, Buckels J, Mayer D, Kelly D. Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood. J Pediatr Gastroenterol Nutr 1998;26:478-81.
34. Sokal EM, Sokol R, Cormier V, et al. Liver transplantation in mitochondrial respiratory chain disorders. Eur J Pediatr 1999; 158(Suppl 2):S81-4.
35. Sussman NB. Fulminant hepatic failure. In: Zakim D, Boyer TD, eds. Hepatology, 3rd ed. Philadelphia: Saunders, 1996: 618-50.
36. Gazzard BG, Portmann B, Murray-Lyon IM, Williams R. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. QJM 1975;44:615-26.
37. Portmann B, Talbot IC, Day DW, Davidson AR, Murray-Lyon IM, Williams R. Histopathological changes in the liver following a acetaminophen overdose: correlation with clinical and biochemical parameters. J Pathol 1975;117:169-81.
38. Horney JT, Galambos JT. The liver during and after fulminant hepatitis. Gastroenterology 1977;73:639-45.
39. Benjamin SB, Goodman ZD, Ishak KG, Zimmerman HJ, Irey NS. The morphologic spectrum of halothane-induced hepatic injury: analysis of 77 cases. Hepatology 1985;5:1163-71.
40. Dupuy JM, Dulac O, Dupuy C, Alagille's D. Severe hyporegenerative viral hepatitis in children. Proc R Soc Med 1977;70:228-32.
41. Odaib AA, Shneider BL, Bennett MJ, et al. A defect in the transport of long-chain fatty acids associated with acute liver failure. N Engl J Med 1998;339:1752-7.
42. Davis MA, Peters RL, Redeker AG, Reynolds TB. Appraisal of the mortality in acute fulminant viral hepatitis. N Engl J Med 1968;278:1248-53.
43. Sawhey VK, Knauer CM, Gregory PB. Rapid reduction of transaminase levels in fulminant hepatitis. N Engl J Med 1980; 302:970.
44. Berk PD, Popper H. Fulminant hepatic failure. Annotated abstracts of a workshop held at the National Institutes of Health, 1977. Am J Gastroenterol 1978;69:349-400.
45. Basile AS, Jones EA. Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology 1997;25:1303-5.
46. Blei AT. Brain edema and portal-systemic encephalopathy. Liver Transpl 2000;6(4 Suppl 1):S14-20.
47. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-21.
48. Alonso EM, Sokol RJ, Hart J, Tyson RW, Narkewicz MR, Whitington PF. Fulminant hepatitis associated with centrilobu-lar necrosis in young children. J Pediatr 1995;127:888-94.
49. Devictor D, Tahiri C, Rousset A, Massenavette B, Russo M, Huault G. Management of fulminant hepatic failure in children- an analysis of 56 cases. Crit Care Med 1993;21(9 Suppl):S348-9.
50. Kucharski SA. Fulminant hepatic failure. Crit Care Nurs Clin North Am 1993;5:141-51.
51. Munoz SJ. Difficult management problems in fulminant hepatic failure. Semin Liv Dis 1993;13:395-413.
52. Larcher VF, Wyke RJ, Mowat AP, Williams R. Bacterial and fungal infection in children with fulminant hepatic failure: possible role of opsonisation and complement deficiency. Gut 1982;23:1037-43.
53. Vilstrup H, Iversen J, Tygstrup N. Glucoregulation in acute liver failure. Eur J Clin Invest 1986;16:193-7.
54. Walsh TS, Wigmore SJ, Hopton P, Richardson R, Lee A. Energy expenditure in acetaminophen-induced fulminant hepatic failure. Crit Care Med 2000;28:649-54.
55. Clark SJ, Shojaee-Moradie F, Croos P, et al. Temporal changes in insulin sensitivity following the development of acute liver failure secondary to acetaminophen. Hepatology 2001;34:109-15.
56. Harry R, Auzinger G, Wendon J. The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology 2002;36:395-402.
57. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81-3.
58. Bansky G, Meier PJ, Riederer E, Walser H, Ziegler WH, Schmid M. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Gastroenterology 1989; 97:744-50.
59. O'Brien CJ, Wise RJS, O'Grady JG, Williams R. Neurological sequelae in patients recovered from fulminant hepatic failure. Gut 1987;28:93-5.
60. Lidofsky SD, Bass NL, Prager MC, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology 1992;16:1-7.
61. Keays R, Potter D, O'Grady J, Peachey T, Alexander G, Williams R. Intracranial and cerebral perfusion pressure changes before, during, and immediately after orthotopic liver transplantation for fulminant hepatic failure. QJM 1991;79:425-33.
62. Jalan R, Olde Damink SW, Deutz NE, et al. Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation 2003;75:2034-9.
63. Belanger M, Desjardins P, Chatauret N, Rose C, Butterworth RF. Mild hypothermia prevents brain edema and attenuates up-regulation of the astrocytic benzodiazepine receptor in experimental acute liver failure. J Hepatol 2005;42:694-9.
64. Keays RT, Alexander GJ, Williams R. The safety and value of extradural intracranial pressure monitors in fulminant hepatic failure. J Hepatol 1993;18:205-9.
65. Record CO, Iles RA, Cohen RD, Williams R. Acid-base and metabolic disturbances in fulminant hepatic failure. Gut 1975; 16:144-9.
66. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in acetaminophen-induced acute liver failure: a cohort study. Lancet 2002;359:558-63.
67. Wilkinson SP, Hurst D, Portmann B, Williams R. Pathogenesis of renal failure in cirrhosis and fulminant hepatic failure. Postgrad Med J 1975;51:503-5.
68. Bihari DJ, Gimson AE, Williams R. Cardiovascular, pulmonary and renal complications of fulminant hepatic failure. Semin Liver Dis 1986;6:119-28.
69. Brown RS Jr, Lombardero M, Lake JR. Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. Transplantation 1996;62:1788-93.
70. Warren R, Trewby JW, Laws JW, Williams R. Pulmonary complications in fulminant hepatic failure: analysis of serial radiographs from 100 consecutive patients. Clin Radiol 1978; 29:363-9.
71. Rolando N, Harvey F, Brahm J, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990;11:49-53.
72. Tzakis AG, Arditi M, Whitington PF, et al. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med 1988;319:393-6.
73. Sussman NL, Chong MG, Koussayer T, et al. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 1992;16:60-5.
74. Horslen SP, Hammel JM, Fristoe LW, et al. Extracorporeal liver perfusion using human and pig livers for acute liver failure. Transplantation 2000;70:1472-8.
75. Singer AL, Olthoff KM, Kim H, Rand E, Zamir G, Shaked A. Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg 2001;234:418-24.
76. Hughes RD, Williams R. Use of bioartificial and artificial liver support devices. Semin Liver Dis 1996;16:435-44.
77. LePage EB, Rozga J, Rosenthal P, et al. A bioartificial liver used as a bridge to liver transplantation in a 10-year-old boy. Am J Crit Care 1994;3:224-7.
78. Okamoto K, Kurose M, Ikuta Y, et al. Prolonged artificial liver support in a child with fulminant hepatic failure. ASAIO J 1996;42:233-5.
79. Nadalin S, Heuer M, Wallot M, et al. Paediatric acute liver failure and transplantation: the University of Essen experience. Transpl Int 2007;20:519-27.
80. Tissieres P, Sasbon JS, Devictor D. Liver support for fulminant hepatic failure: is it time to use the molecular adsorbents recycling system in children? Pediatr Crit Care Med 2005;6:585-91.
81. Hommann M, Kasakow LB, Geoghegan J, et al. Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old child Pediatr Transplant 2002;6:340-3.
82. Covic A, Goldsmith DJA, Gusbeth-Tatomir P, et al. Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver Int 2003;23(Suppl 3):21-7.
83. Nussler A, Konig S, Ott M, et al. Present status and perspectives of cell-based therapies for liver diseases. J Hepatol 2006;45: 144-59.
84. Schneider A, Attaran M, Meier PN, et al. Hepatocyte transplantation in an acute liver failure due to mushroom poisoning. Transplantation 2006;82:1115-6.
85. O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastro-enterology 1989;97:439-45.
86. Brems JJ, Hiatt JR, Ramming KP, Quinones-Baldrich WJ, Busuttil RW. Fulminant hepatic failure: the role of liver transplantation as primary therapy. Am J Surg 1987;154:137-41.
87. Superina RA, Pearl RH, Roberts EA, et al. Liver transplantation in children: the initial Toronto experience. J Pediatr Surg 1989; 24:1013-9.
88. Emond JC, Aran PP, Whitington PF, Broelsch CE, Baker AL. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 1989;96:1583-8.
89. Emre S, Schwartz ME, Shneider B, et al. Living related liver transplantation for acute liver failure in children. Liver Transpl Surg 1999;5:161-5.
90. Miwa S, Hashikura Y, Mita A, et al. Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure. Hepatology 1999;30:1521-6.
91. Mack CL, Ferrario M, Abecassis M, Whitington PF, Superina RA, Alonso EM. Living donor liver transplantation for children with liver failure and concurrent multiple organ system failure. Liver Transpl 2001;7:890-5.
92. Rivera-Penera T, Moreno J, Skaff C, McDiarmid S, Vargas J, Ament ME. Delayed encephalopathy in fulminant hepatic failure in the pediatric population and the role of liver transplantation. J Pediatr Gastroenterol Nutr 1997;24:128-34.
93. Jaeck D, Pessaux P, Wolf P. Which types of graft to use in patients with acute liver failure? (A) Auxiliary liver transplant (B) Living donor liver transplantation (C) The whole liver. (A) I prefer auxiliary liver transplant. J Hepatol 2007;46:570-3.
94. Kato T, Selvaggi G, Levi D, et al. Routine use of auxiliary partial orthotopic liver transplantation for children with fulminant hepatic failure: preliminary report. Transplant Proc 2006;38: 3607-8.
95. Trey C, Lipworth L, Davidson CS. Parameters influencing survival in the first 318 patients report to the fulminant hepatic failure surveillance study [abstract]. Gastroenterology 1970;58:306.
96. Tygstrup N, Ranek L. Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis 1986;6:129-37.
97. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000;6:163-9.
98. O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988;94:1186-92.
99. Ee LC, Shepherd RW, Cleghorn GJ, et al. Acute liver failure in children: a regional experience. J Paediatr Child Health 2003;39:107-10.
100. Bhaduri BR, Mieli-Vergani G. Fulminant hepatic failure: pedi-atric aspects. Semin Liv Dis 1996;16:349-55.
101. Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis 1996;16:403-14.
102. Baliga P, Alvarez S, Lindblad A, Zeng L. Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT Experience. Liver Transplantation 2004;10:1364-71.
103. Karvountzis GG, Redeker AG, Peters RL. Long term follow-up studies of patients surviving fulminant viral hepatitis. Gastro-enterology 1974;67:870-7.